Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00199_DB00361_nanopub.RAnuM0ksW-M1BrLrvAXCLHCYwyNs2CzGGPx4OrtWogKYk#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00199_DB00361 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00199_DB00361 label "DDI between Erythromycin and Vinorelbine - Erythromycin, a CYP3A4 and p-glycoprotein inhibitor, may increase the Vinorelbine serum concentration and distribution in certain cells. Consider alternate therapy to avoid Vinorelbine toxicity. Monitor for changes in the therapeutic and adverse effects of Vinorelbine if Erythromycin is initiated, discontinued or dose changed. [drugbank_resource:DB00199_DB00361]" assertion.
- drugbank_resource:DB00199_DB00361 identifier "drugbank_resource:DB00199_DB00361" assertion.
- drugbank_resource:DB00199_DB00361 title "DDI between Erythromycin and Vinorelbine - Erythromycin, a CYP3A4 and p-glycoprotein inhibitor, may increase the Vinorelbine serum concentration and distribution in certain cells. Consider alternate therapy to avoid Vinorelbine toxicity. Monitor for changes in the therapeutic and adverse effects of Vinorelbine if Erythromycin is initiated, discontinued or dose changed." assertion.
- drugbank:DB00361 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00199_DB00361 assertion.
- drugbank:DB00199 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00199_DB00361 assertion.